Evidence map›Paper›PMID 15386471›Full record

ArticleAmerican journal of medical genetics. Part A2004

Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor.

Mohammed A Junaid, Dagmar Kowal, Madhabi Barua, Premila S Pullarkat, Susan Sklower Brooks, Raju K Pullarkat

Abstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Intact corticostriatal function in aged system xTranslational psychiatry · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Association betweenFrontiers in endocrinology · 2023
    Article
  7. The Human Glyoxalase Gene Family in Health and Disease.Chemical research in toxicology · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.International journal of molecular sciences · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammed A JunaidDepartment of Developmental Biochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York.
Dagmar Kowal
Madhabi Barua
Premila S Pullarkat
Susan Sklower Brooks
Raju K Pullarkat

Funding

Brain Protein Abnormalities in AutismR21NS040691 · NINDS · INSTITUTE FOR BASIC RES IN DEV DISABIL · PI JUNAID, MOHAMMED A · 2001 to 2003
$606k
NINDS NIH HHS NS40691NINDS NIH HHS R21 NS040691NINDS NIH HHS R21 NS040691-01A1
6 · The paper itself

Abstract

Autism is a neurodevelopmental disability characterized by deficits in verbal communications, impairments in social interactions, and repetitive behaviors. Several studies have indicated strong involvement of multigenic components in the etiology of autism. Linkage analyses and candidate gene search approaches so far have not identified any reliable susceptibility genes. We are using a proteomic approach to identify protein abnormalities due to aberrant gene expression in autopsied autism brains. In four of eight autism brains, we have found an increase in polarity (more acidic) of glyoxalase I (Glo1) by two-dimensional gel electrophoresis. To identify the molecular change resulting in the shift of Glo1 polarity, we undertook sequencing of GLO1 gene. Direct sequencing of GLO1 gene/mRNA in these brains, has identified a single nucleotide polymorphism (SNP), C419A. The SNP causes an Ala111Glu change in the protein sequence. Population genetics of GLO1 C419A SNP studied in autism (71 samples) and normal and neurological controls (49 samples) showed significantly higher frequency for the A419 (allele frequency 0.6 in autism and 0.4 in controls, one-tailed Fisher's test P < 0.0079). Biochemical measurements have revealed a 38% decrease in Glo1 enzyme activity in autism brains (one-tailed t-test P < 0.026). Western blot analysis has also shown accumulation of advanced glycation end products (AGE's) in autism brains. These data suggest that homozygosity for A419 GLO1 resulting in Glu111 is a predisposing factor in the etiology of autism.

Indexed as

Polymorphism, Single NucleotideAdolescentAdultAgedAutistic DisorderAutopsyBase SequenceBlotting, WesternChildChild, PreschoolDNADNA Mutational AnalysisElectrophoresis, Gel, Two-DimensionalFemaleGenetic Predisposition to DiseaseHumansDNALactoylglutathione LyaseProteome

Identifiers

PMID15386471
PMCPMC1360505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.